Ashley Cordova Novo Cure LTD (NVCR) insider trading activity

Ashley Cordova is Chief Executive Officer of NovoCure Ltd. Currently has a direct ownership of 437,569 shares of NVCR, which is worth approximately $4.95 Million. The most recent transaction as insider was on Mar 08, 2022, when has been sold 759 shares (Ordinary Shares) at a price of $70.1 per share, resulting in proceeds of $53,206. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 438K

0% 3M change

99.3% 12M change

Total Value Held $4.95 Million

Ashley Cordova Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 08 2022	SELL Open market or private sale	$53,206 $70.1 p/Share	759 Reduced 1.23%	60,848 Ordinary Shares
Mar 04 2022	SELL Open market or private sale	$39,148 $70.41 p/Share	556 Reduced 0.89%	61,607 Ordinary Shares
Mar 03 2022	SELL Open market or private sale	$85,600 $74.5 p/Share	1,149 Reduced 1.81%	62,163 Ordinary Shares
Mar 03 2022	BUY Exercise of conversion of derivative security	$68,191 $13.53 p/Share	5,040 Added 7.11%	65,888 Ordinary Shares
Mar 03 2022	BUY Grant, award, or other acquisition	-	21,508 Added 25.36%	63,312 Ordinary Shares
Jan 06 2022	BUY Grant, award, or other acquisition	$2,936 $63.82 p/Share	46 Added 0.11%	41,804 Ordinary Shares
Nov 02 2021	SELL Open market or private sale	$22,422 $107.28 p/Share	209 Reduced 0.5%	41,758 Ordinary Shares

Sep 02 2021	SELL Open market or private sale	$114,454 $138.23 p/Share	828 Reduced 1.93%	41,967 Ordinary Shares
Aug 12 2021	SELL Open market or private sale	$3,752,120 $140.93 p/Share	26,624 Reduced 36.66%	45,993 Ordinary Shares
Aug 12 2021	SELL Bona fide gift	-	1,733 Reduced 3.77%	44,260 Ordinary Shares
Aug 12 2021	BUY Exercise of conversion of derivative security	$1,249,977 $34.13 p/Share	36,624 Added 42.97%	48,599 Ordinary Shares
Jul 06 2021	BUY Grant, award, or other acquisition	$13,712 $137.12 p/Share	100 Added 0.28%	35,993 Ordinary Shares
Mar 08 2021	SELL Open market or private sale	$100,070 $130.81 p/Share	765 Reduced 2.09%	35,893 Restricted Share Units
Mar 04 2021	SELL Bona fide gift	-	910 Reduced 2.42%	36,658 Ordinary Shares
Mar 04 2021	SELL Open market or private sale	$77,991 $137.55 p/Share	567 Reduced 1.49%	37,568 Restricted Share Units
Mar 02 2021	SELL Open market or private sale	$65,077 $152.05 p/Share	428 Reduced 1.55%	27,249 Restricted Share Units
Mar 02 2021	BUY Grant, award, or other acquisition	-	10,886 Added 22.21%	38,135 Restricted Share Units
Feb 27 2021	BUY Exercise of conversion of derivative security	$218,432 $149.1 p/Share	1,465 Added 5.03%	27,677 Ordinary Shares
Nov 02 2020	SELL Open market or private sale	$27,004 $117.41 p/Share	230 Reduced 0.87%	26,212 Ordinary Shares

Ashley Cordova

Chief Executive Officer

Malvern, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVCR shares.

Notify only if

Value

Insider Trading

Get notified when an Novo Cure LTD insider buys or sells NVCR shares.

Notify only if

Operation

Value

Type

News

Receive news related to NovoCure Ltd

Track Activities on NVCR

Account